Sionna Therapeutics (SION) Current Assets (2024 - 2026)

Sionna Therapeutics has disclosed Current Assets across 3 years of filings, most recently posting $221.0 million for Q1 2026.

• Current Assets for Q1 2026 came in at $221.0 million, down 19.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $221.0 million (down 19.26% YoY), and the FY2025 annual result was $241.4 million, up 59.89% from the prior year.
• Current Assets came in at $221.0 million for Q1 2026 at Sionna Therapeutics, down from $241.4 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $273.7 million in Q1 2025 to a low of $151.0 million in Q4 2024.
• The 3-year median for Current Assets is $246.9 million (2025), against an average of $234.4 million.
• Across the five-year window, Current Assets jumped 59.89% in 2025 and slipped 19.26% in 2026, its largest moves.
• Sionna Therapeutics' Current Assets stood at $151.0 million in 2024, then surged by 59.89% to $241.4 million in 2025, then retreated by 8.47% to $221.0 million in 2026.
• The last three Current Assets figures came in at $221.0 million (Q1 2026), $241.4 million (Q4 2025), and $252.3 million (Q3 2025), per Business Quant data.